Shea Jacqueline Elizabeth
Insider CIK 1771498 · INO Chief Operating Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 100,240 | — | $0 | 100,240 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-05-20 | 2026-05-21 | 28,296 | — | $0 | 56,592 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-05-20 | 2026-05-21 | 123,760 | — | $0 | 123,760 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-05-20 | 2026-05-21 | 12,306 | $1.23 | $15.1K | 111,021 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-05-20 | 2026-05-21 | 28,296 | — | $0 | 123,327 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-05-15 | 2026-05-18 | 17,744 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-05-15 | 2026-05-18 | 17,744 | — | $0 | 102,748 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-05-15 | 2026-05-18 | 7,717 | $1.30 | $10.0K | 95,031 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-03-04 | 2026-03-05 | 78,760 | — | $0 | 78,760 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2026-03-04 | 2026-03-05 | 97,240 | — | $0 | 97,240 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-26 | 2026-02-27 | 28,401 | — | $0 | 56,800 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2026-02-26 | 2026-02-27 | 18,632 | — | $0 | 18,631 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-02-26 | 2026-02-27 | 8,057 | $1.79 | $14.4K | 70,260 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-02-26 | 2026-02-27 | 28,401 | — | $0 | 98,661 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2026-02-26 | 2026-02-27 | 13,657 | $1.79 | $24.4K | 85,004 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2026-02-26 | 2026-02-27 | 18,632 | — | $0 | 78,317 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-05-20 | 2025-05-21 | 84,888 | — | $0 | 84,888 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-05-20 | 2025-05-21 | 105,262 | — | $0 | 105,262 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-05-15 | 2025-05-16 | 17,744 | — | $0 | 17,744 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2025-05-15 | 2025-05-16 | 7,717 | $1.95 | $15.0K | 59,685 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-05-15 | 2025-05-16 | 17,744 | — | $0 | 67,402 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-05-10 | 2025-05-12 | 5,500 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-05-10 | 2025-05-12 | 5,500 | — | $0 | 52,050 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2025-05-10 | 2025-05-12 | 2,392 | $1.80 | $4.3K | 49,658 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-02-27 | 2025-02-28 | 85,201 | — | $0 | 85,201 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2025-02-27 | 2025-02-28 | 105,649 | — | $0 | 105,649 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-26 | 2025-02-28 | 5,852 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2025-02-26 | 2025-02-28 | 18,632 | — | $0 | 37,263 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-02-26 | 2025-02-28 | 18,632 | — | $0 | 55,638 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2025-02-26 | 2025-02-28 | 5,852 | — | $0 | 39,499 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2025-02-26 | 2025-02-28 | 2,493 | $1.98 | $4.9K | 37,006 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2025-02-26 | 2025-02-28 | 9,088 | $1.98 | $18.0K | 46,550 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-15 | 2024-05-16 | 17,745 | — | $0 | 35,488 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2024-05-15 | 2024-05-16 | 7,718 | $13.07 | $100.9K | 33,647 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-05-15 | 2024-05-16 | 17,745 | — | $0 | 41,365 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-05-10 | 2024-05-13 | 5,500 | — | $0 | 5,500 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-05-10 | 2024-05-13 | 5,500 | — | $0 | 26,012 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2024-05-10 | 2024-05-13 | 2,392 | $10.65 | $25.5K | 23,620 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-02-28 | 2024-02-28 | 55,895 | — | $0 | 55,895 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2024-02-28 | 2024-02-28 | 69,733 | — | $0 | 69,733 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-26 | 2024-02-28 | 5,853 | — | $0 | 5,852 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2024-02-26 | 2024-02-28 | 1,878 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2024-02-26 | 2024-02-28 | 2,856 | $8.16 | $23.3K | 20,512 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-02-26 | 2024-02-28 | 5,853 | — | $0 | 23,368 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2024-02-26 | 2024-02-28 | 1,878 | — | $0 | 18,387 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2024-02-26 | 2024-02-28 | 872 | $8.16 | $7.1K | 17,515 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-05-15 | 2023-05-17 | 638,800 | — | $0 | 638,800 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-05-10 | 2023-05-12 | 66,000 | — | $0 | 132,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-05-10 | 2023-05-12 | 66,000 | — | $0 | 226,817 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2023-05-10 | 2023-05-12 | 28,704 | $0.81 | $23.3K | 198,113 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-03-11 | 2023-03-13 | 59,737 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2023-03-11 | 2023-03-13 | 25,980 | $1.13 | $29.4K | 160,817 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-03-11 | 2023-03-13 | 59,737 | — | $0 | 186,797 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2023-02-27 | 2023-02-28 | 836,800 | — | $0 | 836,800 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-02-26 | 2023-02-28 | 22,544 | — | $0 | 22,544 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2023-02-26 | 2023-02-28 | 70,234 | — | $0 | 140,466 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2023-02-26 | 2023-02-28 | 9,788 | $1.28 | $12.5K | 89,311 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-02-26 | 2023-02-28 | 22,544 | — | $0 | 99,099 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2023-02-26 | 2023-02-28 | 70,234 | — | $0 | 159,545 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2023-02-26 | 2023-02-28 | 32,485 | $1.28 | $41.6K | 127,060 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-10 | 2022-05-11 | 198,000 | — | $0 | 198,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-05-10 | 2022-05-11 | 309,400 | — | $0 | 309,400 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-03-25 | 2022-03-28 | 16,666 | — | $0 | 0 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2022-03-25 | 2022-03-28 | 7,247 | $3.63 | $26.3K | 76,555 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-03-25 | 2022-03-28 | 16,666 | — | $0 | 83,802 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-03-11 | 2022-03-14 | 59,737 | — | $0 | 59,737 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-03-11 | 2022-03-14 | 59,737 | — | $0 | 93,110 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2022-03-11 | 2022-03-14 | 25,974 | $3.22 | $83.6K | 67,136 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-02-26 | 2022-03-01 | 210,700 | — | $0 | 210,700 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2022-02-26 | 2022-03-01 | 22,545 | — | $0 | 45,088 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2022-02-26 | 2022-03-01 | 282,300 | — | $0 | 282,300 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2022-02-26 | 2022-03-01 | 22,545 | — | $0 | 44,137 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2022-02-26 | 2022-03-01 | 10,764 | $3.22 | $34.7K | 33,373 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-06-09 | 2021-06-11 | 38,535 | $10.01 | $385.7K | 21,592 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-03-26 | 2021-03-26 | 4,710 | $8.97 | $42.2K | 60,127 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-25 | 2021-03-26 | 16,667 | — | $0 | 16,666 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2021-03-25 | 2021-03-26 | 7,247 | $9.06 | $65.7K | 64,837 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-03-25 | 2021-03-26 | 16,667 | — | $0 | 72,084 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-03-12 | 2021-03-12 | 16,881 | $10.06 | $169.8K | 55,417 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-03-11 | 2021-03-12 | 59,737 | — | $0 | 119,474 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2021-03-11 | 2021-03-12 | 25,974 | $10.57 | $274.5K | 72,298 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-03-11 | 2021-03-12 | 59,737 | — | $0 | 98,272 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-02-26 | 2021-02-26 | 104,833 | — | $0 | 104,833 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2021-02-26 | 2021-02-26 | 67,633 | — | $0 | 67,633 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-02-01 | 2021-02-03 | 22,376 | — | $0 | 100,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-02-01 | 2021-02-03 | 5,960 | $15.00 | $89.4K | 38,535 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-02-01 | 2021-02-03 | 22,376 | $15.06 | $337.0K | 44,495 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-02-01 | 2021-02-03 | 22,376 | $3.62 | $81.0K | 66,871 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-01-28 | 2021-01-29 | 55,248 | — | $0 | 122,376 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-01-28 | 2021-01-29 | 16,713 | $12.04 | $201.2K | 44,495 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-01-28 | 2021-01-29 | 55,248 | $3.62 | $200.0K | 61,208 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2021-01-27 | 2021-01-29 | 22,376 | — | $0 | 177,624 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-01-27 | 2021-01-29 | 5,960 | $12.04 | $71.8K | 5,960 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | S Sale | 2021-01-27 | 2021-01-29 | 22,376 | $12.01 | $268.7K | 11,920 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2021-01-27 | 2021-01-29 | 22,376 | $3.62 | $81.0K | 34,296 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise deriv | 2020-03-25 | 2020-03-26 | 16,667 | — | $0 | 33,333 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | F Tax w/h | 2020-03-25 | 2020-03-26 | 4,747 | $6.68 | $31.7K | 11,920 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | M Exercise | 2020-03-25 | 2020-03-26 | 16,667 | — | $0 | 16,667 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2020-03-11 | 2020-03-12 | 179,211 | — | $0 | 179,211 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-03-25 | 2019-03-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INO INOVIO PHARMACEUTICALS, IN | A Award deriv | 2019-03-25 | 2019-03-27 | 200,000 | — | $0 | 200,000 | SEC↗ |